Yahoo Suche Web Suche

Suchergebnisse

1. Suchergebnisse:

1. finance.yahoo.com › news › abbvie-abbv-skyrizi-gets-chmpAbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU

   finance.yahoo.com › news › abbvie-abbv-skyrizi-gets-chmp

   • Im Cache

   Vor 20 Stunden · AbbVie (ABBV) announces that the EMA's CHMP issued a positive opinion on its regulatory filing seeking label expansion for the immunology drug, Skyrizi, to treat UC.

2. markets.businessinsider.com › news › stocksAbbVie Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU

   markets.businessinsider.com › news › stocks

   • Im Cache

   Vor 20 Stunden · Jun. 3, 2024, 03:32 PM. AbbVie (NYSE:ABBV) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion ...

3. www.krstarica.com › zivot › ziveti-zivotDa li se odbijanjem kumstva priziva nesreća i maler ... -...

   www.krstarica.com › zivot › ziveti-zivot

   • Im Cache

   Vor 20 Stunden · Da li se odbijanjem kumstva priziva nesreća i maler? Sveštenik rešio dilemu koja muči mnoge Srbe. „BOG na nebu, kum na zemlji“ i „Kumstvo se ne odbija“- stare su narodne izreke koje ste verovatno nebrojano puta čuli. Kumstvo spada u duhovno srodstvo. Kum se bira pri krštenju, kao duhovni otac detetu i na venčanju, kao svedok ...

4. www.fiercepharma.com › marketing › abbvies-humira-20-drugAbbVie's Humira 2.0 drugs to help sales rebound, growth: report

   www.fiercepharma.com › marketing › abbvies-humira-20-drug

   • Im Cache

   Vor 20 Stunden · The firm, which estimates that sales of Humira over its more than 20-year life have hit a staggering $187 billion, drilled down the drug’s bleak sales future. Having lost U.S. patent protection ...